BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29477751)

  • 1. Immune complexome analysis of antigens in circulating immune complexes from patients with acute cellular rejection after living donor liver transplantation.
    Aibara N; Ohyama K; Hidaka M; Kishikawa N; Miyata Y; Takatsuki M; Eguchi S; Kuroda N
    Transpl Immunol; 2018 Jun; 48():60-64. PubMed ID: 29477751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune complexome analysis of serum and its application in screening for immune complex antigens in rheumatoid arthritis.
    Ohyama K; Ueki Y; Kawakami A; Kishikawa N; Tamai M; Osaki M; Kamihira S; Nakashima K; Kuroda N
    Clin Chem; 2011 Jun; 57(6):905-9. PubMed ID: 21482748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective, sensitive and comprehensive detection of immune complex antigens by immune complexome analysis with papain-digestion and elution.
    Aibara N; Kamohara C; Chauhan AK; Kishikawa N; Miyata Y; Nakashima M; Kuroda N; Ohyama K
    J Immunol Methods; 2018 Oct; 461():85-90. PubMed ID: 30158077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal grafts protect daughter recipients from acute cellular rejection after pediatric living donor liver transplantation for biliary atresia.
    Sanada Y; Kawano Y; Miki A; Aida J; Nakamura K; Shimomura N; Ishikawa N; Arai T; Hirata Y; Yamada N; Okada N; Wakiya T; Ihara Y; Urahashi T; Yasuda Y; Takubo K; Mizuta K
    Transpl Int; 2014 Apr; 27(4):383-90. PubMed ID: 24472036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation.
    Raschzok N; Reutzel-Selke A; Schmuck RB; Morgul MH; Gauger U; Prabowo KA; Tannus LM; Leder A; Struecker B; Boas-Knoop S; Bartels M; Jonas S; Lojewski C; Puhl G; Seehofer D; Bahra M; Pascher A; Pratschke J; Sauer IM
    Liver Transpl; 2015 Sep; 21(9):1195-207. PubMed ID: 25950774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of glutathione S-transferase T1 gene polymorphisms on acute cellular rejection in living donor liver transplantation.
    Kamei H; Masuda S; Nakamura T; Fujimoto Y; Oike F; Ogura Y; Takada Y; Hamajima N
    Transpl Immunol; 2013 Jan; 28(1):14-7. PubMed ID: 23153768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of transporter associated with antigen processing (TAP) gene polymorphisms in donors with acute cellular rejection in living donor liver transplantation.
    Kamei H; Masuda S; Nakamura T; Oike F; Takada Y; Hamajima N
    J Gastrointestin Liver Dis; 2013 Jun; 22(2):167-71. PubMed ID: 23799215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of alanine aminopeptidase N (APN) in bile in the diagnosis of acute cellular rejection after liver transplantation.
    Kim C; Aono S; Marubashi S; Wada H; Kobayashi S; Eguchi H; Takeda Y; Tanemura M; Okumura N; Takao T; Doki Y; Mori M; Nagano H
    J Surg Res; 2012 Jun; 175(1):138-48. PubMed ID: 21550066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-mediated rejection in pediatric liver transplant recipients.
    Markiewicz-Kijewska M; Kaliciński P; Kluge P; Piątosa B; Rękawek A; Jankowska I; Kostecka E; Kurowski PN
    Ann Transplant; 2014 Mar; 19():119-23. PubMed ID: 24594760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of interleukin4 gene polymorphisms of recipients and donors with acute rejection following living donor liver transplantation.
    Kamei H; Masuda S; Ishigami M; Nakamura T; Fujimoto Y; Takada Y; Hamajima N
    Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):179-85. PubMed ID: 26212175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients.
    Boix F; Millan O; San Segundo D; Mancebo E; Rimola A; Fabrega E; Fortuna V; Mrowiec A; Castro-Panete MJ; Peña Jde L; Llorente S; Minguela A; Bolarin JM; Paz-Artal E; Lopez-Hoyos M; Brunet M; Muro M
    Immunobiology; 2016 May; 221(5):595-603. PubMed ID: 26850323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-transplant donor-specific Interferon-gamma-producing cells and acute rejection of the kidney allograft.
    Slavcev A; Rybakova K; Svobodova E; Slatinska J; Honsova E; Skibova J; Viklicky O; Striz I
    Transpl Immunol; 2015 Oct; 33(2):63-8. PubMed ID: 26254561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of maternal grafts in early acute cellular rejection after pediatric living-donor liver transplantation.
    Noguchi Y; Ueno T; Kodama T; Saka R; Takama Y; Tazuke Y; Bessho K; Okuyama H
    Pediatr Surg Int; 2019 Jul; 35(7):765-771. PubMed ID: 31111216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of B cells in acute kidney transplant rejection.
    Carpio VN; Noronha Ide L; Martins HL; Jobim LF; Gil BC; Külzer AS; Loreto Mda S; Gonçalves LF; Manfro RC; Veronese FV
    Exp Clin Transplant; 2014 Oct; 12(5):405-14. PubMed ID: 25299368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes in pediatric renal allograft rejection.
    Jordan SC; Sakai R; Malekzadeh MH; Pennisi AJ; Ettenger RB; Uittenbogaart CH; Fine RN
    Transplantation; 1981 Mar; 31(3):190-4. PubMed ID: 7015615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes during various forms of renal allograft rejection episodes.
    Jordan SC; Sakai R; Ettenger RB; Fine RN
    Nephron; 1982; 31(2):141-5. PubMed ID: 6750420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intragraft transcriptome level of CXCL9 as biomarker of acute cellular rejection after liver transplantation.
    Asaoka T; Marubashi S; Kobayashi S; Hama N; Eguchi H; Takeda Y; Tanemura M; Wada H; Takemasa I; Takahashi H; Ruiz P; Doki Y; Mori M; Nagano H
    J Surg Res; 2012 Dec; 178(2):1003-14. PubMed ID: 22889476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers in serum of acute cellular rejection after liver transplantation.
    Jiang Q; Ru Y; Yu Y; Li K; Jing Y; Wang J; Li G
    Transpl Immunol; 2019 Apr; 53():7-12. PubMed ID: 30472391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for acute liver allograft rejection and their influences on treatment outcomes of rescue therapy in living donor liver transplantation.
    Shindoh J; Akamatsu N; Tanaka T; Kaneko J; Tamura S; Sakamoto Y; Hasegawa K; Sugawara Y; Makuuchi M; Kokudo N
    Clin Transplant; 2016 Aug; 30(8):880-5. PubMed ID: 27146588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of acute cellular rejection between living donor liver transplantation and cadaveric liver transplantation].
    Fan S; Zhang Z
    Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(18):1092-4. PubMed ID: 11766604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.